BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22682780)

  • 1. Social anxiety and functional impairment in patients seeking surgical evaluation for hyperhidrosis.
    Schneier FR; Heimberg RG; Liebowitz MR; Blanco C; Gorenstein LA
    Compr Psychiatry; 2012 Nov; 53(8):1181-6. PubMed ID: 22682780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperhidrosis and social anxiety disorder--the same old thing under a different cloak?].
    Nahaloni E; Iancu I
    Harefuah; 2014 Oct; 153(10):595-9, 624. PubMed ID: 25518078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in clinical presentation between depressed outpatients wanting versus not wanting treatment for comorbid social anxiety disorder.
    Dalrymple KL; Zimmerman M
    J Nerv Ment Dis; 2008 Aug; 196(8):639-42. PubMed ID: 18974677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbid social withdrawal (hikikomori) in outpatients with social anxiety disorder: clinical characteristics and treatment response in a case series.
    Nagata T; Yamada H; Teo AR; Yoshimura C; Nakajima T; van Vliet I
    Int J Soc Psychiatry; 2013 Feb; 59(1):73-8. PubMed ID: 21997765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in recognition and treatment of social anxiety disorder: a 10-year retrospective.
    Stein MB
    Psychopharmacol Bull; 2003; 37 Suppl 1():97-107. PubMed ID: 14566205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional impairment in social anxiety disorder.
    Aderka IM; Hofmann SG; Nickerson A; Hermesh H; Gilboa-Schechtman E; Marom S
    J Anxiety Disord; 2012 Apr; 26(3):393-400. PubMed ID: 22306132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptance and commitment therapy for generalized social anxiety disorder: a pilot study.
    Dalrymple KL; Herbert JD
    Behav Modif; 2007 Sep; 31(5):543-68. PubMed ID: 17699117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the trial-based thought record, a new cognitive therapy strategy designed to change core beliefs, in social phobia.
    de Oliveira IR; Powell VB; Wenzel A; Caldas M; Seixas C; Almeida C; Bonfim T; Grangeon MC; Castro M; Galvão A; de Oliveira Moraes R; Sudak D
    J Clin Pharm Ther; 2012 Jun; 37(3):328-34. PubMed ID: 21955037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhidrosis in social anxiety disorder.
    Davidson JR; Foa EB; Connor KM; Churchill LE
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Dec; 26(7-8):1327-31. PubMed ID: 12502021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
    Allgulander C; Mangano R; Zhang J; Dahl AA; Lepola U; Sjödin I; Emilien G;
    Hum Psychopharmacol; 2004 Aug; 19(6):387-96. PubMed ID: 15303242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drinking motives in alcohol use disorder patients with and without social anxiety disorder.
    Cooper R; Hildebrandt S; Gerlach AL
    Anxiety Stress Coping; 2014 Jan; 27(1):113-22. PubMed ID: 23915169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial aspects of patients with focal hyperhidrosis. Marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A.
    Weber A; Heger S; Sinkgraven R; Heckmann M; Elsner P; Rzany B
    Br J Dermatol; 2005 Feb; 152(2):342-5. PubMed ID: 15727649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom overlap between autism spectrum disorder, generalized social anxiety disorder and obsessive-compulsive disorder in adults: a preliminary case-controlled study.
    Cath DC; Ran N; Smit JH; van Balkom AJ; Comijs HC
    Psychopathology; 2008; 41(2):101-10. PubMed ID: 18033980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social anxiety disorder: what are we losing with the current diagnostic criteria?
    Filho AS; Hetem LA; Ferrari MC; Trzesniak C; Martín-Santos R; Borduqui T; de Lima Osório F; Loureiro SR; Busatto Filho G; Zuardi AW; Crippa JA
    Acta Psychiatr Scand; 2010 Mar; 121(3):216-26. PubMed ID: 19694635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social anxiety disorder: questions and answers for the DSM-V.
    Bögels SM; Alden L; Beidel DC; Clark LA; Pine DS; Stein MB; Voncken M
    Depress Anxiety; 2010 Feb; 27(2):168-89. PubMed ID: 20143427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of persistence of social anxiety disorder: a national study.
    Blanco C; Xu Y; Schneier FR; Okuda M; Liu SM; Heimberg RG
    J Psychiatr Res; 2011 Dec; 45(12):1557-63. PubMed ID: 21875720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fear of Positive Evaluation Scale: psychometric properties in a clinical sample.
    Fergus TA; Valentiner DP; McGrath PB; Stephenson K; Gier S; Jencius S
    J Anxiety Disord; 2009 Dec; 23(8):1177-83. PubMed ID: 19700259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An atypical anxious-impulsive pattern of social anxiety disorder in an adult clinical population.
    Mörtberg E; Tillfors M; van Zalk N; Kerr M
    Scand J Psychol; 2014 Aug; 55(4):350-6. PubMed ID: 24716675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An epidemiologic perspective on social anxiety disorder.
    Stein MB
    J Clin Psychiatry; 2006; 67 Suppl 12():3-8. PubMed ID: 17092189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric properties of disability measures among patients with social anxiety disorder.
    Hambrick JP; Turk CL; Heimberg RG; Schneier FR; Liebowitz MR
    J Anxiety Disord; 2004; 18(6):825-39. PubMed ID: 15474855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.